BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36254860)

  • 1. Rapid improvement of Mycobacterium kansasii pneumonia after rifabutin, isoniazid, and ethambutol: A case report.
    Kuo HI; Huang ST; Wu YH
    Kaohsiung J Med Sci; 2022 Nov; 38(11):1137-1138. PubMed ID: 36254860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pain, swelling, and progressive weakness of the left knee over 6 years].
    Pelfort X; Horcajada JP; Puig L; Salvadó M
    Enferm Infecc Microbiol Clin; 2008 Nov; 26(9):595-6. PubMed ID: 19100182
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
    Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
    Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Swelling of right knee in an immunologically compromised patient].
    Cajigas-Pezo D; Lorenzo-Hernandez A; Vives-Rivero GR; Rentero-Martínez Z
    Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):481-2. PubMed ID: 22521279
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fever and thin-walled cavitary lung lesions].
    Ramos A; Daza R; Alvarez-Espejo T; Guzmán MF
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):363-4. PubMed ID: 19419797
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arthritis due to Mycobacterium kansasii in a woman with human immunodeficiency virus infection].
    Puerto JL; García-Martos P; Saldarreaga A; Ruiz-Aragón J; Mira J
    Enferm Infecc Microbiol Clin; 2007 Apr; 25(4):289. PubMed ID: 17386226
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disseminated disease by Mycobacterium kansasii resistant to isoniazid and rifampin in patients] with AIDS].
    Ibarrola M; Baraia-Etxaburu J; Sánchez R; Teira R; Unzaga J; Miguel Santamaría J
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(2):80-2. PubMed ID: 11333577
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethambutol-induced bullous skin lesions in
    Kollipara VK; Horowitz M; Lantz J; Nagy-Agren S
    Int J Mycobacteriol; 2022; 11(1):120-122. PubMed ID: 35295035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium kansasii infection of the spine in a patient with sarcoidosis: a case report and literature review.
    Bakhsh WR; Mesfin A
    J Surg Orthop Adv; 2014; 23(3):162-5. PubMed ID: 25153815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
    Cosson MA; Bertrand JB; Martin C; Veziris N; Picard C; Goulvestre C; Coignard S; Benoit JP; Silvera S; Moro MR; Poyart C; Morand PC
    J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium malmoense infection. An unusual cause of wrist swelling.
    Syed AA; O'Flanagan J
    J Hand Surg Br; 1998 Dec; 23(6):811-2. PubMed ID: 9888690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium kansasii olecranon bursitis.
    Barham GS; Hargreaves DG
    J Med Microbiol; 2006 Dec; 55(Pt 12):1745-1746. PubMed ID: 17108281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system infection and cutaneous lymphadenitis due to Mycobacterium kansasii in an immunocompetent patient.
    Tabatabaei N; Stout J; Goldschmidt-Clermont P; Murdoch D
    Infection; 2007 Jun; 35(4):291-4. PubMed ID: 17646914
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man.
    Bekou V; Büchau A; Flaig MJ; Ruzicka T; Hogardt M
    BMC Dermatol; 2011 Jan; 11():3. PubMed ID: 21269422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].
    Mori M; Ageshio F; Kagawa H; Oshitani Y; Fujikawa T; Saito H; Sako H; Yano Y; Kitada S; Maekura R
    Kekkaku; 2015 Aug; 90(8):619-23. PubMed ID: 26665518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and epidemiological characteristics of M. kansasii pulmonary infections from Rio de Janeiro, Brazil, between 2006 and 2016.
    Goldenberg T; Gayoso R; Mogami R; Lourenço MC; Ramos JP; Carvalho LD; Dalcolmo MP; Mello FCQ
    J Bras Pneumol; 2020; 46(6):e20190345. PubMed ID: 32696934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of disease due to Mycobacterium kansasii.
    Griffith DE
    Clin Chest Med; 2002 Sep; 23(3):613-21, vi. PubMed ID: 12370997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium kansasii.
    Johnston JC; Chiang L; Elwood K
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of isoniazid chemoprophylaxis during infliximab therapy.
    Fernández-Guerrero ML; Esteban J; Acebes C; Górgolas M
    Emerg Infect Dis; 2007 Sep; 13(9):1428-9. PubMed ID: 18252132
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment alternatives for Mycobacterium kansasii.
    Graybill JR; Bocanegra R
    J Antimicrob Chemother; 2001 Apr; 47(4):417-20. PubMed ID: 11266413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.